Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04389593 · ClinicalTrials.gov registry record
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 30
- Enrollment target
NCT04389593 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 30 participants.
The verdict
NCT04389593 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This pilot study will evaluate conventional and investigational MR imaging and spectroscopic sequences and collect data to help plan more definitive future studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-05-21 |
| Est. Completion | 2024-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04389593
The ClinicalTrials.gov registry entry for NCT04389593 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04389593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04389593 about?
NCT04389593 is a clinical study titled "Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference". This pilot study will evaluate conventional and investigational MR imaging and spectroscopic sequences and collect data to help plan more definitive future studies.
What is the current status of trial NCT04389593?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-05-21. Estimated completion is 2024-07-12.
Who is sponsoring clinical trial NCT04389593?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.